CTRI/2025/11/097196Not yet recruitingPhase 2/3
Comparison Of Peritubal Infiltration and USG guided Erector spinae Plane block for Post operative Analgesia in Percutaneous Nephrolithotomy -A prospective randomised controlled study
Dr D Tulja Bhavani1 site in 1 country60 target enrollmentStarted: November 25, 2025Last updated:
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- To compare the need for first rescue analgesia in both groups- in patients receiving 0.375% Ropivacaine vs patients receiving peri tubal infiltration.
Study Overview
Brief Summary
The primary aim of this study is to assess the VAS scores in population receiving 20ml of 0.375% Ropivacaine in erector spinae block versus population receiving 20ml of 0.375% Ropivacaine through peritubal infiltration in PCNL surgeries for post operative analgesia, to measure and compare the total analgesic consumption in both the groups.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Investigator Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •ASA-1and ASA-2patients of either sex
- •Patients of age between 18-60years of age
- •Patients posted for elective percutaneous nephrolithotomy under general Anaesthesia.
Exclusion Criteria
- •1.Patient refusal 2.Patients with known hypersensitivity to known local Anesthetic drug 3.Patients with bleeding diathesis , uncontrolled diabetes mellitus and severe hepatorenal disease .
- •Patients with epilepsy and mentally unstable patients 5.Pregnant and lactating women
- •Patients on chronic analgesic therapy and anticoagulants.
- •Patients with cardio respiratory, neurological or psychiatric illness.
- •Renal stones which require more than one puncture , supra coastal puncture intraoperative excessive bleeding 9.Surgical time more than 3hours 10.BMI morethan 35Kg/m2.
Outcomes
Primary Outcomes
To compare the need for first rescue analgesia in both groups- in patients receiving 0.375% Ropivacaine vs patients receiving peri tubal infiltration.
Time Frame: at 0,2,4,6,8,10,12,16,18 | and 24hours in both groups.
Secondary Outcomes
- to compare the total analgesic consumption(at 0,2,4,6,8,10,12,16,18 till 24 hours)
Investigators
Dr D Tulja Bhavani
Rajarajeswari medical college and Hospital
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 3
Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).NCT07265232Lantu Biopharma15
Not yet recruiting
Not Applicable
Comparing Perfusion Index and Visual analogue scale for post operative pain assessmentCTRI/2025/07/090080Dr. Rashmi R Aithal42
Not yet recruiting
Not Applicable
Comparison of Postop Analgesia using USG guided Adductor canal block with Ropivacaine alone versus Ropivacaine with Fentanyl in knee and below knee surgeries;A Randomised Controlled TrialCTRI/2025/11/097564KALPANA CHAWLA MEDICAL COLLEGE120
Not yet recruiting
Phase 4
Regional anaesthesia with three different drug doses in sick and elderly patients with hip fractureCTRI/2025/08/09349460
Completed
Not Applicable
Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPHBenign Prostatic HyperplasiaNCT07306767Ain Shams University130